Syros Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference
September 10 2020 - 8:30AM
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development
of medicines that control the expression of genes, today announced
that its Chief Executive Officer, Nancy Simonian, M.D., will
present a corporate overview at the Cantor Virtual Global
Healthcare Conference. Details are as follows:
Cantor Virtual Global Healthcare Conference: Date:
Thursday, September 17 Time: 8:40 a.m. ET
A live webcast of the presentation will be available on the
Investors & Media section of the Syros website at
www.syros.com. An archived replay of the webcast will be available
for approximately 30 days following the presentation.
About Syros Pharmaceuticals
Syros is redefining the power of small molecules to control the
expression of genes. Based on its unique ability to elucidate
regulatory regions of the genome, Syros aims to develop medicines
that provide a profound benefit for patients with diseases that
have eluded other genomics-based approaches. Syros is advancing a
robust pipeline, including SY-1425, a first-in-class oral selective
RARα agonist in a Phase 2 trial in a genomically defined subset of
acute myeloid leukemia patients, and SY-5609, a highly selective
and potent oral CDK7 inhibitor in a Phase 1 trial in patients with
select solid tumors. Syros also has multiple preclinical and
discovery programs in oncology and monogenic diseases. For more
information, visit www.syros.com and follow us on Twitter
(@SyrosPharma) and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200910005012/en/
Media Contact: Naomi Aoki Syros Pharmaceuticals
617-283-4298 naoki@syros.com Investor Contact: Hannah
Deresiewicz Stern Investor Relations, Inc. 212-362-1200
hannah.deresiewicz@sternir.com
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Sep 2023 to Sep 2024